Literature DB >> 21142588

Estonia at the threshold of the fourth decade of the AIDS era in Europe.

Kaja-Triin Laisaar1, Radko Avi, Jack DeHovitz, Anneli Uusküla.   

Abstract

This article describes the trends of HIV/AIDS and related conditions in Estonia during the past decade (2000-2009), with special focus on the potential for epidemic transition. Key transmission determinants and major risk groups are examined and problems and barriers to fighting HIV/AIDS with possible applications in prevention and control are described. Estonian routine data sources and published literature were reviewed, supplemented with information from personal communication with physicians and public health specialists. For comparative European data, international HIV/AIDS and drug addiction surveillance documents, administrative data, and published literature were reviewed. In Eastern Europe (including Estonia) the predominant HIV transmission mode is injection drug use (IDU), closely followed by heterosexual transmission, an increasing risk factor for new cases. Although the contribution of cases acquired by sexual contact with high-risk partners such as IDUs is not known, characteristics of the sexual networks of IDUs may be important in determining the evolution of the HIV/AIDS epidemics in the region. In Estonia, despite major gaps in available data, the HIV/AIDS epidemic is still presumably confined to IDUs (and probably, to their sexual partners). In Eastern Europe, young women in IDU-non-IDU partnerships engaging in unprotected sex potentially serve as a bridge to the general population, yet knowledge of and research into the population characteristics and potential magnitude of bridging are limited. In Estonia, as in other Eastern European countries, HIV prevention and harm reduction initiatives should be tailored not only to the predominantly male HIV-positive IDU population, but also to their noninfected non-IDU female sexual partners.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21142588      PMCID: PMC3180763          DOI: 10.1089/aid.2010.0223

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  29 in total

1.  Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia.

Authors:  Radko Avi; Kristi Huik; Maarja Sadam; Tonis Karki; Tonu Krispin; Külliki Ainsalu; Piret Paap; Jelena Schmidt; Natalia Nikitina; Irja Lutsar
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-19       Impact factor: 2.205

2.  The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners.

Authors:  Linda M Niccolai; Irina S Shcherbakova; Olga V Toussova; Andrei P Kozlov; Robert Heimer
Journal:  J Urban Health       Date:  2009-06-09       Impact factor: 3.671

Review 3.  HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Authors:  Bradley M Mathers; Louisa Degenhardt; Hammad Ali; Lucas Wiessing; Matthew Hickman; Richard P Mattick; Bronwyn Myers; Atul Ambekar; Steffanie A Strathdee
Journal:  Lancet       Date:  2010-02-26       Impact factor: 79.321

4.  Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia.

Authors:  K Abel-Ollo; M Rahu; K Rajaleid; A Talu; K Ruutel; L Platt; N Bobrova; T Rhodes; A Uuskula
Journal:  AIDS Care       Date:  2009-07

5.  Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia.

Authors:  Radko Avi; Kristi Huik; Merit Pauskar; Valentina Ustina; Tonis Karki; Tonu Krispin; Külliki Ainsalu; Piret Paap; Jelena Schmidt; Natalia Nikitina; Irja Lutsar
Journal:  Scand J Infect Dis       Date:  2010-10-21

6.  HIV risk behaviour knowledge, substance use and unprotected sex in men who have sex with men in Tallinn, Estonia.

Authors:  A Tripathi; K Rüütel; R D Parker
Journal:  Euro Surveill       Date:  2009-12-03

7.  Syphilis and gonorrhoea in men who have sex with men: a European overview.

Authors:  E J Savage; G Hughes; C Ison; C M Lowndes
Journal:  Euro Surveill       Date:  2009-11-26

8.  HIV and AIDS in the European Union, 2008.

Authors:  M J van de Laar; G Likatavicius
Journal:  Euro Surveill       Date:  2009-11-26

9.  Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.

Authors:  Radko Avi; Kristi Huik; Maarja Sadam; Tonis Karki; Tonu Krispin; Külliki Ainsalu; Piret Paap; Jelena Schmidt; Natalia Nikitina; Irja Lutsar
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

10.  HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.

Authors:  Ave Talu; Kristiina Rajaleid; Katri Abel-Ollo; Kristi Rüütel; Mati Rahu; Tim Rhodes; Lucy Platt; Natalia Bobrova; Anneli Uusküla
Journal:  Int J Drug Policy       Date:  2009-04-22
View more
  9 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

2.  Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010.

Authors:  Radko Avi; Kristi Huik; Merit Pauskar; Valentina Ustina; Tõnis Karki; Eveli Kallas; Ene-Ly Jõgeda; Tõnu Krispin; Irja Lutsar
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-05       Impact factor: 2.205

3.  Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Med Microbiol Immunol       Date:  2015-12-22       Impact factor: 3.402

4.  Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia.

Authors:  Robert Heimer; Nina Usacheva; Russell Barbour; Linda M Niccolai; Anneli Uusküla; Olga S Levina
Journal:  Addiction       Date:  2017-05-04       Impact factor: 6.526

5.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Viral Immunol       Date:  2016-08-26       Impact factor: 2.257

6.  Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia.

Authors:  Kaja-Triin Laisaar; Anneli Uusküla; Anjali Sharma; Jack A DeHovitz; K Rivet Amico
Journal:  AIDS Care       Date:  2013-02-07

7.  Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.

Authors:  Anneli Uusküla; Don C Des Jarlais; Mart Kals; Kristi Rüütel; Katri Abel-Ollo; Ave Talu; Igor Sobolev
Journal:  BMC Public Health       Date:  2011-06-30       Impact factor: 3.295

8.  Cryptosporidiosis - an occupational risk and a disregarded disease in Estonia.

Authors:  Brian Lassen; Marie Ståhl; Heidi L Enemark
Journal:  Acta Vet Scand       Date:  2014-06-05       Impact factor: 1.695

9.  Addressing injecting drug use in Asia and Eastern Europe.

Authors:  Zunyou Wu; Cynthia X Shi; Roger Detels
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.